Non-alcoholic fatty liver disease |
29 |
149 |
1.92E-25 |
ADIPOQ,ATF4,CASP3,CASP8,CEBPA,CXCl8,CYCS,CYP2E1,DDIT3,EIF2AK3,EIF2S1,FAS,IKBKB,IL1A,IL1B,IL6,INS,LEP,MAPK8,MAPK9,NFKB1,NR1H3,CASP,SREBF1,TNF |
Pathways in cancer |
43 |
515 |
3.15E-25 |
AGTR1,AKT,BIRC3,CASP3,CASP8,CCND1,CEBPA,CXCl8,CX4R4,CYCS,EGFR,EPAS1,FZR,FAS,FGFR1,FOXO1,HMOX1,IFNA1,IGF1,IKBKB,IL6,LPAR1,MAPK3,MAPK8,MAPK9,NFKB1,NGF,PIK3CA,PPARG,PTGS2,RELA,STAT3,TGFB1 |
Insulin resistance |
25 |
107 |
6.77E-24 |
ADIPOQ,CD36,CPT1A,CPT1B,CREB1,FOXO1,IKBKB,IL6,INS,MAPK8,MAPK9,NFKB1,NR1H3,OGT,PCK2,PIK3CA,PPARA,PPARGC1A,PTEN,RELA,SLC2A4 |
AGE-RAGE signaling pathway in diabetic complications |
23 |
98 |
4.62E-22 |
AGTR1,CASP3,CCL5,CCND1,COL1A1,CXCl8,EGFR,FOXO1,IL1A,IL1B,IL6,MAPK3,MAPK8,MAPK9,NFKB1,PIK3CA,RELA,SELE,SERPINE1,STAT3,TNF |
IL-17 signaling pathway |
23 |
108 |
5.48E-21 |
ATF4,BIRC3,CASP3,CASP8,CCL2,CEBPB,CREB1,CXCl10,FAS,IKBKB,IL1B,IL6,MAPK8,MAPK9,NFKB1,MMP9,NFKB1,PIK3CA,PTGS2,RELA,TNF |
PPAR signaling pathway |
20 |
72 |
1.67E-20 |
ACSL5,ADIPOQ,ANGPTL4,APOA1,APOA5,APOC3,CD36,CPT1A,CPT1B,FABP1,PADS2,LPL,NR1H3,PCK2,PLIN2,PPARA,PPARD,PPARG,SCD,SLC27A1 |
Hepatitis B |
24 |
142 |
2.48E-20 |
ATF4,CASP3,CASP8,CCND1,CREB1,CXCl8,CYCS,FAS,IFNA1,IKBKB,IL6,MAPK3,MAPK8,MAPK9,MMP9,MYC,NFKB1,PIK3CA,PTEN,RELA,STAT3,TGFB1,TLR4,TNF |
Adipocytokine signaling pathway |
18 |
69 |
4.19E-18 |
ACACB,ACSL5,ADIPOQ,CD36,CPT1A,CPT1B,IKBKB,LEP,MAPK8,MAPK9,NFKB1,PCK2,POMC,PPARA,PPARGC1A,RELA,STAT3,TNF |
AMPK signaling pathway |
21 |
120 |
4.22E-18 |
ACACB,ADIPOQ,CCND1,CD36,CPT1A,CPT1B,CREB1,FASN,FOXO1,FOXO3,HMGCR,IGF1,INS,LEP,PCK2,PIK3CA,PPARG,PPARGC1A,SCD,SIRT1,SLC2A4 |
FoxO signaling pathway |
20 |
130 |
2.75E-16 |
CAT,CCND1,EGFR,FOXO1,FOXO3,IGF1,IKBKB,IL10,IL6,INS,MAPK8,MAPK9,MAPK9,PCK2,PIK3CA,PTEN,SIRT1,SOD2,STAT3,TGFB1 |
p53 signaling pathway |
18 |
92 |
2.75E-16 |
CASP3,CASP8,CCND1,CYCS,DDIT3,FOXO3,IGF1,MAPK8,MAPK9,MAPK9,NFKB1,PIK3CA,RELA,SERPINE1,TGFB1,TLR4,TNF |
Chagas disease (American trypanosomiasis) |
18 |
101 |
1.04E-15 |
CASP8,CCL2,CXCl8,FAS,IKBKB,IL10,IL1B,IL6,MAPK8,MAPK8,MAPK9,NFKB1,PIK3CA,RELA,SERPINE1,TGFB1,TLR4,TNF |
Influenza A |
20 |
168 |
1.89E-14 |
CASP1,EIF2AK2,FOXO3,IFNA1,IKBKB,IL1A,IL1B,IL6,MAPK8,MAPK8,MAPK9,NFKB1,PIK3CA,RELA,TLR4,TNF |
TNF-Akt signaling pathway |
26 |
348 |
2.43E-14 |
ATF4,BDNF,CCND1,CREB1,EGFR,FGFR1,FGF21,IGF1,IKBKB,IL1A,IL1B,IL6,INS,KDR,MAPK8,MAPK3,MAPK8,MAPK9,MYC,NFKB1,NGF,RELA,TGFB1,TN,PIK3CA,PTEN |
MAPK signaling pathway |
24 |
293 |
4.58E-14 |
ATF4,BDNF,CASP3,DDIT3,EGFR,FAS,FGF21,IGF1,IKBKB,IL1A,IL1B,INS,KDR,MAPK8,MAPK3,MAPK8,MAPK9,MYC,NFKB1,NGF,RELA,TGFB1,TN,FYSEN5 |
Hepatitis C |
18 |
131 |
4.66E-14 |
CXCl8,EGFR,EIF2AK3,EIF2S1,IFNA1,IKBKB,LDL-R,MAPK3,MAPK8,MAPK9,NFKB1,NR1H3,PIK3CA,PPARA,PSM E3,RELA,STAT3,TNF |
Kaposi's sarcoma-associated herpesvirus infection |
20 |
183 |
6.44E-14 |
CASP3,CASP8,CCND1,CREB1,CXCl8,CYCS,FAS,IFNA1,IKBKB,IL6,MAPK3,MAPK8,MAPK9,MYC,NFKB1,PIK3CA,PTGS2,RELA,STAT3,VEGFA |
Apoptosis |
18 |
135 |
6.65E-14 |
ATF4,BIRC3,CASP3,CASP8,CYCS,DDIT3,EIF2AK3,EIF2S1,FAS,IKBKB,MAPK8,MAPK8,MAPK9,NFKB1,NGF,PIK3CA,RELA,TNF |